The emerging therapy of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide909216.blog-eye.com/42357797/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment